| Autor: |
Hong CC; Departments of Medicine, Physiology, and Biochemistry and Molecular Biology, Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, United States. |
| Jazyk: |
angličtina |
| Zdroj: |
Frontiers in drug discovery [Front Drug Discov (Lausanne)] 2022; Vol. 2. Date of Electronic Publication: 2022 Sep 23. |
| DOI: |
10.3389/fddsv.2022.1027401 |
| Abstrakt: |
Competing Interests: Conflict of interest The author has consulted for Ipsen, La Jolla Pharmaceuticals and ATsens, Inc.; and received royalties from Keros Therapeutics. He is also the founder of Proton Bio, Inc. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
